Journal Publications
Project Data Sphere's success is ultimately measured by the practice-changing scientific insights discovered by the research community. We are proud to share the following list of peer-accepted publications, and we are grateful to the data providers, research scientists, and patients that make this possible.
| Author(s) | Date |
Article Title |
Journal |
|---|---|---|---|
|
H-G Eichler, B Bloechl-Daum, P Bauer, F Bretz, J Brown, LV Hampson, P Honig, M Krams, H Leufkens, R Lim, MM Lumpkin, MJ Murphy, F Pignatti, M Posch, S Schneeweiss, M Trusheim, F Koenig |
September 2016 | “Threshold‐crossing”: A Useful Way to Establish the Counterfactual in Clinical Trials? | Clinical Pharmacology & Therapeutics |
|
Omar Abdel-Rahman, Jennifer Spratlin, Sheryl Koski |
March 2020 | Vitamin and herbal supplements' use among patients with advanced gastrointestinal cancers included in eight clinical trials | Journal of Cancer Research and Clinical Oncology |
|
Khaled El Emam, Lucy Mosquera, Xi Fang |
October 2022 | Validating a membership disclosure metric for synthetic health data | Jamia Open |
|
Tomohiro Ohigashi, Kazushi Maruo, Takashi Sozu, Masahiko Gosho |
April 2022 | Using horseshoe prior for incorporating multiple historical control data in randomized controlled trials | Sage Journals |
|
Massimiliano Zanin |
November 2017 | Using complex networks for refining survival prognosis in prostate cancer patient | F1000 Research |
|
Motoki Shiga |
November 2017 | Two-step feature selection for predicting survival time of patients with metastatic castrate resistant prostate cancer | F1000 Research |
|
Celine Yeh, Mengxi Zhou, Keith Sigel, Gayle Jameson, Ruth White, Rachael Safyan, Yvonne Saenger, Elizabeth Hecht, John Chabot, Stephen Schreibman, Béata Juzyna, Marc Ychou, Thierry Conroy, Tito Fojo, Gulam A Manji, Daniel Von Hoff, Susan E Bates |
November 2022 | Tumor Growth Rate Informs Treatment Efficacy in Metastatic Pancreatic Adenocarcinoma: Application of a Growth and Regression Model to Pivotal Trial and Real-World Data | The Oncologist |
|
Kaiwen Deng, Hongyang Li, and Yuanfang Guan |
February 2020 | Treatment Stratification of Patients with Metastatic Castration-Resistant Prostate Cancer by Machine Learning | iScience |
|
T.Elumalai, C.Barker, T.Elliott, J.Malik, A.Tran, A.Hudson, Y.P.Song, K.Patel, J.Lyons, P.Hoskin, A.Choudhury, H.Mistry |
March 2022 | Translation of Prognostic and Pharmacodynamic Biomarkers from Trial to Non-trial Patients with Metastatic Castration-resistant Prostate Cancer Treated with Docetaxel | Clinical Oncology |
|
Michael J. Kane |
June 2021 | Towards a Grammar for Processing Clinical Trial Data | R Journal Volume |
|
Quentin Le Coënt, Catherine Legrand, Virginie Rondeau |
November 2022 | Time-to-event surrogate endpoint validation using mediation analysis and meta-analytic data | Biostatistics |
|
Tobias Klatte, Kevin M. Gallagher, Luca Afferi, Alessandro Volpe, Nils Kroeger, Silvia Ribback, Alan McNeill, Antony C. P. Riddick, James N. Armitage, Tevita F. Aho, Tim Eisen, Kate Fife, Axel Bex, Allan J. Pantuck, Grant D. Stewart |
October 2019 | The VENUSS prognostic model to predict disease recurrence following surgery for non-metastatic papillary renal cell carcinoma: development and evaluation using the ASSURE prospective clinical trial cohort | BMC Medicine |
|
Steffen Ventz, PhD, Leah Comment, PhD, Bill Louv, PhD, Rifaquat Rahman, MD, Patrick Y Wen, MD, Brian M Alexander, MD, Lorenzo Trippa, PhD |
June 2021 | The Use of External Control Data for Predictions and Futility Interim Analyses in Clinical Trials | Neuro-Oncology |
|
Kald Abdallah, Charles Hugh-Jones, Thea Norman, Stephen Friend, Gustavo Stolovitzky |
May 2015 | The Prostate Cancer DREAM Challenge: A Community-Wide Effort to Use Open Clinical Trial Data for the Quantitative Prediction of Outcomes in Metastatic Prostate Cancer | The Oncologist |
